药典标准品是指由国家药品监督管理局认定并公布的、用于药物质量控制的标准物质,其纯度、含量及稳定性等特性已经过严格验证。药典标准品在确保药品质量和安全性方面起着至关重要的作用。
杂质标准品则是指用于检测药物中可能存在的各种类型杂质的化学试剂或混合物。与药典标准品不同的是,杂质标准品不一定是单一化合物的标准品,它们可以是特定类型的杂质或是代表性的杂质混合物,旨在帮助制药企业进行质量控制和开发更为严格的生产工艺。
两者在药品生产和监管中都发挥着重要作用:药典标准品用于检测药物的主要成分是否符合规定的含量范围;而杂质标准品则有助于识别、定量分析并降低潜在的有害杂质,从而确保最终产品的安全性和有效性。在研发新药或改进现有药物的过程中,正确使用这些标准品可以有效提高产品质量和安全性评估水平。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
(S)-N-[(2S,4S,5S)-5-氨基-4-羟基-1,6-二苯基己烷-2-基]-3-甲基-2-(2-氧代四氢嘧啶-1(2H)-基)丁酰胺 | (2S)-N-[(2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexane-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide | 192726-05-9 | C27H38N4O3 |
|
(S)-N-(1-氮杂双环环[2.2.2]-3-辛基)-5,6,7,8-四氢-1-萘羧酰胺 | N-<(S)-1-azabicyclo<2.2.2>oct-3-yl>-5,6,7,8-tetrahydronaphthalene-1-carboxamide | 135729-78-1 | C18H24N2O |
|
(S)-5-(2-氨丙基)-2-甲氧苯磺酰胺 | (S)-(+)-5-(2-aminopropyl)-2-methoxybenzene sulfonamide | 119714-13-5 | C10H16N2O3S |
|
(S)-4-溴-3-羟基丁酸乙酯 | (+/-)-4-Brom-3-hydroxy-buttersaeureethylester | 32224-01-4 | C6H11BrO3 |
|
(S)-4-氯-3-羟基丁醛 | (S)-4-Chloro-3-hydroxy-butyraldehyde | 125781-04-6 | C4H7ClO2 |
|
(S)-4-氯-1,3-丁二醇 | (3S)-4-chloro-1,3-butanediol | 139013-68-6 | C4H9ClO2 |
|
(S)-4-叔丁氧-2-异丙基-4-氧丁酸 | (S)-4-(tert-butoxy)-2-isopropyl-4-oxobutanoic acid | 134807-43-5 | C11H20O4 |
|
(S)-4-(4-硝基苄基)-2-噁唑烷酮 | (S)-4-(4-nitrobenzyl)-1,3-oxazolidin-2-one | 139264-55-4 | C10H10N2O4 |
|
(S)-4-(3-((叔-丁氧羰基)氨基)-1-(异喹啉-6-基氨基)-1-氧亚基丙烷-2-基)苯甲基2,4-二甲基苯酸盐 | (S)-4-(3-((tert-butoxycarbonyl)amino)-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate | 1253955-19-9 | C33H35N3O5 |
|
(S)-3-羟基-1-甲基吡咯烷-2,5-二酮 | 3-hydroxy-N-methylsuccinimide | 131237-81-5 | C5H7NO3 |
|
(S)-3-甲基-1-[2-(1-哌啶基)苯基]丁胺 | (S)-3-methyl-1-(2-piperidin-1-yl-phenyl)butylamine | 147769-93-5 | C16H26N2 |
|
(S)-3-二甲基氨基-3-苯丙醇 | (S)-(+)-3-(dimethylamino)-3-phenyl-1-propanol | 82769-75-3 | C11H17NO |
|
(S)-2-苄氧基丙醛 | (S)-2-(benzyloxy)propanal | 81445-44-5 | C10H12O2 |
|
(S)-2-氨基丁酸甲酯 | methyl (S)-2-aminobutanoate | 15399-22-1 | C5H11NO2 |
|
(S)-2-乙酰胺基-N-苄基-3-甲氧基丙酰胺 | (S)-2-acetamido-N-benzyl-3-methoxypropanamide | 175481-37-5 | C13H18N2O3 |
|
(S)-1-苯基-1,2,3,4-四氢-2-异喹啉甲酸乙酯 | ethyl (S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate | 180468-42-2 | C18H19NO2 |
|
(S)-1-苄基-3-N-叔丁氧羰基氨基哌啶 | (S)-tert-butyl 1-benzylpiperidin-3-ylcarbamate | 216854-24-9 | C17H26N2O2 |
|
(S)-1-氨基-3-甲基丁基硼酸蒎烷二醇酯三氟醋酸盐 | (1S)-(S)-pinanediol 1-ammonium trifluoroacetate-3-methylbutane-1-boronate | 477254-69-6 | C2HF3O2*C15H28BNO2 |
|
(S)-1-[(4-氯苯基)苯甲基]哌嗪 | (S)-1-((4-chlorophenyl)(phenyl)methyl)piperazine | 439858-21-6 | C17H19ClN2 |
|
(S)-(-)-托伐普坦 | (S)-tolvaptan | 331947-44-5 | C26H25ClN2O3 |
|
(S)-(-)-3-硫代乙酰-2-甲基丙酸 | (2S)-3-acetylthio-2-methylpropionic acid | 76497-39-7 | C6H10O3S |
|
(R,s)-n-乙酰基-3,4-二甲氧基苯丙氨酸 | N-acetyl-3,4-dimethoxyphenylalanine | 27313-65-1 | C13H17NO5 |
|
(R,Z)-5-[1,1'-联苯]-4-[[(1,1-二甲基乙氧基)羰基]氨基]-2-甲基-2-戊烯酸 | (Z)-(R)-5-biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methylpent-2-enoic acid | 1361408-16-3 | C23H27NO4 |
|
(R,S)2-(7-甲氧基-1,2,3,4-四氢萘-1-基)乙基乙酰胺 | (R,S) 2-(7-methoxy-1,2,3,4-tetrahydronaphth-1-yl)ethylacetamide | 178677-49-1 | C15H21NO2 |
|
(R)-盐酸乐卡地平 | (R)-Lercanidipine Hydrochloride | 187731-34-6 | C36H42ClN3O6 |
|
(R)-度洛西汀盐酸盐 | (R)-duloxetine hydrochloride | 910138-96-4 | C18H19NOS*ClH |
|
(R)-奎宁环-3-基 羟基二(2-噻吩基)乙酸酯 | (R)-quinuclidin-3-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate | 320347-97-5 | C17H19NO3S2 |
|
(R)-噻唑烷-4-羧酸乙酯 | ethyl L-thiazolidine-4-carboxylate | 60664-15-5 | C6H11NO2S |
|
(R)-噻唑烷-4-甲酸甲酯 | (R)-thiazolidine-4-carboxylic acid methyl ester | 42258-90-2 | C5H9NO2S |
|
(R)-叔-丁基7-(2-(4-氟苯基)-5-异丙基-3-苯基-4-(苯氨羰基)-1H-吡咯-1-基)-5-羟基-3-氧亚基庚酯 | 1,1-dimethylethyl (R)-7-<2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-<(phenylamino)carbonyl>-1H-pyrrol-1-yl>-5-hydroxy-3-oxo-1-heptanoate | 134394-98-2 | C37H41FN2O5 |
|
(R)-利斯的明 | (R)-3-(1-(dimethylamino)ethyl) phenylethyl(methyl)carbamate | 415973-05-6 | C14H22N2O2 |
|
(R)-alpha-[(2,2-二甲基-1-氧代丙基)氨基]-4-羟基苯乙酸 | (R)-2-(4-hydroxyphenyl)-2-pivalamidoacetic acid | 205826-86-4 | C13H17NO4 |
|
(R)-N-环氧丙基邻苯二甲酰亚胺 | (R)-N-(2,3-epoxypropyl)phthalimide | 181140-34-1 | C11H9NO3 |
|
(R)-N-去甲基氧氟沙星 | N-Desmethyl ofloxacin, (R)- | 117707-39-8 | C17H18FN3O4 |
|
(R)-N-(2,4-二羟基-3,3-二甲基-1-氧代丁基)-beta-丙氨酸甲酯 | methyl pantothenate | 50692-78-9 | C10H19NO5 |
|
(R)-N-(1-(萘-1-基)乙基)-3-(3-(三氟甲基)苯基)丙酰胺 | (R)-N-(1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide | 1005450-55-4 | C22H20F3NO |
|
(R)-5-(叔丁氧基)-5-氧代-4-(4,7,10-三(2-(叔丁氧基)-2-氧代乙基)-1,4,7,10-四氮杂环十二烷-1-戊基)戊酸 | (R)-5-(tert-butoxy)-5-oxo-4-(4,7,10-tris(2-(tert-butoxy)-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl)pentanoic acid | 817562-90-6 | C35H64N4O10 |
|
(R)-5-(2-(2,5-二氟苯基)吡咯烷-1-基)吡唑并[1,5-a]嘧啶-3-胺 | (R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine | 1223404-88-3 | C16H15F2N5 |
|
(R)-4-(4-(3-氨基-2-羟丙胺基)苯基)-3-吗啉酮 | (S)-4-(4-((3-amino-2-hydroxypropyl)amino)phenyl)morpholin-3-one hydrochloride | 1403383-55-0 | C13H19N3O3*ClH |
|
(R)-3-甲基氨基-1-(2-噻吩基)-1-丙醇 | (R)-3-(methylamino)-1-(thiophen-2-yl)propan-1-ol | 116539-57-2 | C8H13NOS |
|
(R)-3-氨基-3-苯基丙酸 | (R)-3-phenyl-3-aminopropionic acid | 13921-90-9 | C9H11NO2 |
|
(R)-3-氧代-5-羟基-6-氰基己酸叔丁酯 | tert-butyl (R)-6-cyano-5-hydroxy-3-oxohexanoate | 125988-01-4 | C11H17NO4 |
|
(R)-3-(4-(5溴-2-氯苄基)苯氧基)四氢呋喃 | (R)-4-bromo-1-chloro-2-(4-tetrahydrofuran-3-yloxy-benzyl)-benzene | 915095-90-8 | C17H16BrClO2 |
|
(R)-2-(2-乙酰叔丁酯基)-戊酸 | (R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid | 112106-16-8 | C11H20O4 |
|
(R)-1-苯基-1,2,3,4-四氢异喹啉-2-甲酸乙酯 | ethyl (R)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate | 180468-41-1 | C18H19NO2 |
|
(R)-(–)-2-氨基丁酰胺盐酸盐 | (R)-2-aminobutanamide hydrochloride | 103765-03-3 | C4H10N2O*ClH |
|
(R)-(R)-1-甲基吡咯烷-3-基2-环戊基-2-羟基-2-苯基醋酸盐 | (3R)-1-methylpyrrolidin-3-yl (2R)-2-cyclopentyl-2-hydroxy-2-phenylacetate | 616866-21-8 | C18H25NO3 |
|
(R)-(+)-托伐普坦 | (+)-Tolvaptan | 331947-66-1 | C26H25ClN2O3 |
|
(N-叔-丁氧羰基-N-[(1’R)-羟基-1-苯基)乙基])-4-硝基苯基乙基胺 | (R)-(2-hydroxy-2-phenylethyl)(4-nitrophenethyl)carbamic acid tert-butyl ester | 223673-35-6 | C21H26N2O5 |
|
(E/Z)-FK-50626,28-烯丙酸酯 | (1R,9S,12R,13E,15S,16S,19R,20E,23S,25S,26R,27S,29R)-1,16-dihydroxy-12-[(1R,3S,4R)-4-hydroxy-3-methoxycyclohexyl]-25,27-dimethoxy-13,15,21,23,29-pentamethyl-19-prop-2-enyl-11,30-dioxa-4-azatricyclo[24.3.1.04,9]triaconta-13,20-diene-2,3,10,18-tetrone | 131944-48-4 | C44H69NO12 |
|